Efficacy and tolerability of perampanel in patients with genetic generalized epilepsy (GGE): A retrospective, single-center study from the United Arab Emirates (UAE).

•52.4% achieved seizure freedom at six months from baseline in our cohort of PWE from the UAE.•38.